IFC, Proparco, DEG, DFC’s Investment in Aspen Pharmacare’s Operations in Africa for EURO 600 million

Lead party: International Finance Corporation (IFC) (investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Aspen Pharmacare Holdings Limited (public company) · Sector: Healthcare, Biotechnology, Medical Supplies, Pharmaceuticals · Countries of operation: Tanzania, Uganda, Mauritius, South Africa, Ghana, Nigeria, Botswana, Namibia, Kenya Transaction type: Debt Financing · Asset class: Private…


Lead party: International Finance Corporation (IFC) (investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Aspen Pharmacare Holdings Limited (public company) · Sector: Healthcare, Biotechnology, Medical Supplies, Pharmaceuticals · Countries of operation: Tanzania, Uganda, Mauritius, South Africa, Ghana, Nigeria, Botswana, Namibia, Kenya

Transaction type: Debt Financing · Asset class: Private Credit · Strategy: Direct Lending · Instrument: Syndicated Loan · Round: Growth Capital · Deal amount: US$714.1m · Fund: European Financing Partners S. A, EFP

Investors/buyers: International Finance Corporation (IFC), Proparco, Deutsche Investitions-und Entwicklungsgesellschaft (DEG), The United States International Development Finance Corporation (DFC), Austrian Development Bank (OeEB), EDFI Management Company

Legal advisers: not identified in the source record.

Source: announced 30 June 2021. Original announcement: ifc.org.